Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Michael Birrer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Birrer, Michael

Item TypeName
Academic Article Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Academic Article Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Academic Article Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.
Academic Article Regulation of tumor angiogenesis by EZH2.
Academic Article Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
Concept Hereditary Breast and Ovarian Cancer Syndrome
Concept Ovarian Neoplasms
Academic Article Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Academic Article CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.
Academic Article A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.
Academic Article Clear cell cancer of the ovary.
Academic Article Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.
Academic Article Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.
Academic Article Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
Academic Article Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Academic Article Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
Academic Article Inherited Mutations in Women With Ovarian Carcinoma.
Academic Article Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus.
Academic Article Characterization of folate receptor alpha (FRa) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRa-targeting antibody-drug conjugate mirvetuximab soravtansine.
Academic Article Genomic analysis of epithelial ovarian cancer.
Academic Article Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.
Academic Article Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Academic Article Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
Academic Article A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
Academic Article Ascites analysis by a microfluidic chip allows tumor-cell profiling.
Academic Article Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
Academic Article ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
Academic Article Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Academic Article A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Academic Article Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
Academic Article Biomarkers in ovarian cancer: To be or not to be.
Academic Article Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.
Academic Article Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
Academic Article Better therapeutic trials in ovarian cancer.
Academic Article Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
Academic Article Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.
Academic Article "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
Academic Article Dicer, Drosha, and outcomes in patients with ovarian cancer.
Academic Article Clear cell carcinoma of the ovary: a review of the literature.
Academic Article RASSF1A and the Taxol Response in Ovarian Cancer.
Academic Article Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Academic Article Validation of serum biomarkers for detection of early-stage ovarian cancer.
Academic Article BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Academic Article Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.
Academic Article Summary and discussion of session recommendations.
Academic Article Biomarkers and clinical trial design.
Academic Article The future of phase II trials.
Academic Article Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Academic Article Biomarker discovery in epithelial ovarian cancer by genomic approaches.
Academic Article Novel therapeutic targets.
Academic Article Molecular subtypes of high-grade serous ovarian cancer: the holy grail?
Academic Article An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
Academic Article Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
Academic Article Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Academic Article Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Academic Article Ovarian cancer: markers of response.
Academic Article Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer.
Academic Article A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
Academic Article Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.
Academic Article Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
Academic Article Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
Academic Article Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
Academic Article Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Academic Article Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies.
Academic Article Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
Academic Article Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
Academic Article Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
Academic Article Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Academic Article GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Academic Article curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome.
Academic Article Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
Academic Article Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.
Academic Article Early tumor detection afforded by in?vivo imaging of near-infrared II fluorescence.
Academic Article Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Academic Article Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Academic Article Variation in resource utilization associated with the surgical management of ovarian cancer.
Academic Article TGF-? modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
Academic Article Restoration of an impaired TGF-beta1 autocrine growth-inhibitory circuit results in growth inhibition of ovarian epithelial cancer cells and complete inhibition of their tumorigenicity.
Academic Article Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
Academic Article Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Academic Article Early events in the pathogenesis of epithelial ovarian cancer.
Academic Article FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.
Academic Article Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Academic Article Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
Academic Article An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Academic Article Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Academic Article Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Academic Article Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.
Academic Article Classification of ovarian cancer: a genomic analysis.
Academic Article Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.
Academic Article Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.
Academic Article IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Academic Article Current challenges and opportunities for research on borderline ovarian tumors.
Academic Article Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer.
Academic Article A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
Academic Article The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Academic Article Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
Academic Article Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target.
Academic Article Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Academic Article A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.
Academic Article Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
Academic Article Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
Academic Article Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.
Academic Article Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Academic Article Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary.
Academic Article Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
Academic Article Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Academic Article Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
Academic Article Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer.
Academic Article Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.
Academic Article Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
Academic Article FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.
Academic Article Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.
Academic Article Ovarian cancer: targeting the untargetable.
Academic Article Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Academic Article Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations.
Academic Article Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.
Academic Article Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.
Academic Article Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Academic Article Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.
Academic Article Carcinosarcoma of the ovary: a review of the literature.
Academic Article Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.
Academic Article Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Academic Article CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
Academic Article EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer.
Academic Article The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.
Academic Article Common variation in Nemo-like kinase is associated with risk of ovarian cancer.
Academic Article Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.
Academic Article Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
Academic Article Ovarian cancer risk associated with inherited inflammation-related variants.
Academic Article Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Academic Article CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Academic Article Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Academic Article FGFR2 mutations are rare across histologic subtypes of ovarian cancer.
Academic Article Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.
Academic Article Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
Academic Article Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
Academic Article Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.
Academic Article Ovarian cancer: not a borderline issue!
Academic Article Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
Academic Article ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.
Academic Article CD157 in ovarian carcinoma: how does it help us?
Academic Article SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.
Academic Article Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
Academic Article A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
Academic Article Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Academic Article The origin of ovarian cancer?is it getting clearer?
Academic Article Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
Academic Article Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Academic Article ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Academic Article Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.
Academic Article Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
Academic Article Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.
Academic Article Time for action: a "sea change" in treatment strategies for rare types of epithelial ovarian cancer.
Academic Article AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
Academic Article Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.
Academic Article Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor a-targeting antibody-drug conjugate, in patients with solid tumors.
Academic Article Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
Academic Article Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.
Academic Article The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
Academic Article Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer.
Academic Article Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.
Academic Article A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Academic Article LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
Academic Article Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Academic Article Etiology and pathogenesis of epithelial ovarian cancer.
Academic Article Biomarkers of mucinous tumors of the ovary.
Academic Article Cell cycle and related protein.
Academic Article Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.
Academic Article A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Academic Article MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
Academic Article Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Academic Article Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect.
Academic Article Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.
Academic Article Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
Academic Article Inhibition of the Wnt/?-catenin pathway enhances antitumor immunity in ovarian cancer.
Academic Article Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Academic Article Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Grant OVARIAN CANCER DETECTION BY UTERINE LAVAGE DNA AND SERUM PROTEINS: A PHASE 2 BIOMARKER STUDY
Grant The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
Grant The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
Grant The Molecular Genetics of Gynecologic Cancers
Grant Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
Grant Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Grant Novel Biomarkers in Ovarian Cancer
Grant Genomic Stratification of Ovarian Cancer Patients
Academic Article p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Academic Article Discoveries in the cell cycle and ovarian cancer.
Academic Article Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations.
Academic Article The molecular genetics of gyn malignancies.
Academic Article FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
Academic Article Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis.
Academic Article N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines.
Academic Article BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
Academic Article FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.
Academic Article Ovarian cancer: genomic analysis.
Academic Article Identification of LMX1B as a novel oncogene in human ovarian cancer.
Academic Article Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
Academic Article Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
Academic Article Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.
Academic Article Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
Academic Article How can molecular abnormalities influence our clinical approach.
Academic Article Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.
Academic Article Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Academic Article Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of M?llerian origin.
Academic Article Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
Academic Article Corrigendum to 'Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer' [Gynecologic Oncology 157 (2020) 765-774].
Academic Article Neutralization of TGF? Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma.
Academic Article Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary?analysis of FORWARD I.
Academic Article Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Academic Article Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
Academic Article Understanding the effect of mechanical forces on ovarian cancer progression.
Grant The Genomic, Epigenomic, and Quality-of-Life Characteristics of Long-Term Survivors of Ovarian Cancer
Academic Article Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.
Academic Article Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Academic Article Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
Academic Article Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.
Academic Article DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer.
Academic Article Targeting NaPi2b in ovarian cancer.
Academic Article Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
Academic Article A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
Academic Article Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
Academic Article DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Academic Article Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Academic Article Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Grant The Genomic, Epigenomic, and Quality-of-Life Characteristics of Long-Term Survivors of Ovarian Cancer
Grant Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
Grant Treatment of Recurrent, Platinum-Resistant Ovarian Cancer with Glutaminase 1 and PARP Inhibitors
Grant Proteomic, Genomic, + Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
Grant Overcoming PARP Inhibitor Resistance of BRCA-Deficient Ovarian Cancers
Academic Article Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.

Search Criteria
  • Ovarian Neoplasms